<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, neuraminidase inhibitors, such as oral oseltamivir, inhaled zanamivir and intravenous peramivir are approved antiviral treatments for influenza and MERS infections; however, oral oseltamivir has been used in patients with COVID-19 infections in China, but to date, there is no convincing evidence of itsâ€™ effectiveness [
 <xref ref-type="bibr" rid="CR25">25</xref>].
</p>
